Bvf Inc Portfolio Holdings

Bvf Inc

  • $2.54 Billion
  • Q2 2025

Bvf Inc has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $2.54 Billion distributed in 44 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Moon Lake Immunotherapeutics with a value of $932M, Kymera Therapeutics, Inc. with a value of $240M, Revolution Medicines, Inc. with a value of $183M, Protagonist Therapeutics, Inc with a value of $177M, and Axsome Therapeutics, Inc. with a value of $176M.

Examining the 13F form we can see an increase of $269M in the current position value, from $2.28B to 2.54B.

Bvf Inc is based out at San Francisco, CA

Below you can find more details about Bvf Inc portfolio as well as his latest detailed transactions.

Portfolio value $2.54 Billion
Healthcare: $2.54 Billion

Stock Holdings Table ETFs Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 44
  • Current Value $2.54 Billion
  • Prior Value $2.28 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 3 stocks
  • Additional Purchases 5 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 6 stocks
Track This Portfolio

Track Bvf Inc Portfolio

Follow Bvf Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bvf Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bvf Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email